- The Food and Drug Administration (FDA) is expected to develop a plan for COVID-19 vaccine boosters by early September.
- Immune compromised patients are at greater risk of not only more severe COVID-19 illness but also “breakthrough infection.”
- Experts say some of the U.S. vaccine stockpile used for booster shots could supply countries with limited access to the vaccines.
As COVID-19 cases have continued to surge, experts are looking at the benefits of COVID-19 vaccines and booster shots, specifically for people who are immunocompromised.
The Food and Drug Administration (FDA) is expected to develop a plan for COVID-19 vaccine boosters by early September. The plan will reportedly explain when and which vaccinated individuals should receive booster shots, according to people familiar with discussions within the agency. This is according to news reports, including those from The Wall Street Journal.
For people with suppressed immune systems, getting clarification can’t come soon enough. These people are eligible for a vaccine, but it may not provide robust protection if their immune system is suppressed.
As a result, many people who are immunocompromised want to know if they can get a booster a shot.
Source: healthline